Teladoc Health, Inc.
US ˙ NYSE ˙ US87918A1051

SecurityTDOC / Teladoc Health, Inc.
InstitutionMarex Group plc
Latest Disclosed Ownership57,314 shares
Latest Disclosed Value $ 312,361
Marex Group plc reports 16.68% increase in ownership of TDOC / Teladoc Health, Inc.

On May 13, 2026 - Marex Group plc filed a 13F-HR form disclosing ownership of 57,314 shares of Teladoc Health, Inc. (US:TDOC) valued at $312,361 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 49,121 shares of Teladoc Health, Inc.. This represents a change in shares of 16.68% during the quarter. The current value of the position is $404,064 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F TELADOC HEALTH COM 87918A105 57,314 8,193 16.68 312 -9.04 0.0013
2026-02-12 2025-12-31 13F TELADOC HEALTH COM 87918A105 49,121 -3,386 -6.45 344 -15.31 0.0022
2025-11-14 2025-09-30 13F TELADOC HEALTH COM 87918A105 52,507 -3,473 -6.20 406 -16.84 0.0029
2025-08-19 2025-06-30 13F TELADOC HEALTH COM 87918A105 55,980 11,013 24.49 488 36.41 0.0042
2026-04-02 2025-03-31 13F TELADOC HEALTH COM 87918A105 44,967 857 1.94 358 -10.75 0.0069
2026-04-02 2024-12-31 13F TELADOC HEALTH COM 87918A105 44,110 -2,882 -6.13 401 -7.19 0.0068
2026-04-07 2024-09-30 13F TELADOC HEALTH COM 87918A105 46,992 -6,196 -11.65 431 -17.12 0.0098
2026-04-02 2024-06-30 13F TELADOC HEALTH COM 87918A105 53,188 -4,697 -8.11 520 -40.50 0.0140
2026-04-02 2024-03-31 13F TELADOC HEALTH COM 87918A105 57,885 4,126 7.67 874 -24.53 0.0284
2026-04-02 2023-12-31 13F TELADOC HEALTH COM 87918A105 53,759 14,770 37.88 1,159 59.94 0.0455
2026-04-02 2023-09-30 13F TELADOC HEALTH COM 87918A105 38,989 -17,378 -30.83 725 -49.26 0.1024
2026-04-02 2023-06-30 13F TELADOC HEALTH COM 87918A105 56,367 -2,501 -4.25 1,427 -6.36 0.2574
2026-04-02 2023-03-31 13F TELADOC HEALTH COM 87918A105 58,868 -8,893 -13.12 1,525 -4.87 0.2019
2026-04-02 2022-12-31 13F TELADOC HEALTH COM 87918A105 67,761 67,761 1,603 0.2277
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.